Friday, March 3, 2017

Patient or Corporate Advocacy Organizations? - New Studies Shed Some Light

Introduction

On Health Care Renewal we frequently discuss how people and institutions entrusted to promote patients' and the public's health instead promote commercial interests.

For example, health care corporations, particularly drug/ biotechnology/ device companies may enlist key opinion leaders (KOLs). These are nominally learned academics and distinguished professionals, but who have

No comments:

Post a Comment

Making the Revolving Door Great Again: Recent FDA Commissioner Dr Scott Gottlieb Joins the Pfizer Board of Directors

It has been less than six weeks since our last post on the revolving door. That post emphasized cases of the outgoing revolving door, that ...